Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)

ALL MBC

• • Molecular Profiling to Study Treatment Selection for Advanced Breast Cancer 
  • Using Personalized T-Cells Along with Chemotherapy to Treat Metastatic Breast Cancer
  • Keytruda plus Bacterial Therapy for Advanced Breast (and Other) Tumors
  • GEN1029 for Advanced Breast (and Other) Cancer
  • ABBV-155 for Advanced Breast (and Other) Cancers

Hormone Receptor Positive (ER+ and/or PR+)

• • A New Targeted Therapy and Taxol for Advanced Breast Cancer
  • ONC201 for Estrogen Receptor Positive or Triple Negative Metastatic Breast Cancer
  • Tecentriq & Cotellic or Idasanutlin for ER+, HER2- Advanced Breast Cancer

HER2 positive (HER2+)

• • DS-8201a Versus Standard of Care for HER2 Positive Advanced Breast Cancer
  • DS-8201a Plus Immunotherapy for HER2 Positive or HER2 Low Expression Advanced Breast Cancer

Triple Negative

• • A New Targeted Therapy and Taxol for Advanced Breast Cancer
  • ONC201 for Estrogen Receptor Positive or Triple Negative Metastatic Breast Cancer
  • XmAb20717 Immunotherapy for Advanced Triple Negative Breast Cancer

Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.

Last Modified on August 25, 2020

Tags:HER2Hormone Receptor PositiveTNBC